[Intraluminal ureteral hematoma complicating anticoagulant therapy].
Intraluminal ureteral hematoma is a rare disease and only a few cases have been previously described. We report a case of intraluminal ureteral hematoma induced by anticoagulant therapy. A 65-year old man having the oral anticoagulant therapy for prevention of secondary thrombolism following atrial fibrillation was referred to us for gross hematuria. Ultrasound sonography (US) revealed right renal mild wide pelvis. Computed tomography (CT) showed the right ureteral submucosal hematoma. This ureteral hematoma penetrated the ureteral mucosa and caused macrohematuria. The patient had been anticoagulated on Warfarin with Bucolome for 18 days, so the prothrombin times (PT) was found to be excessively prolonged beyond the normal therapeutic range. The oral anticoagulation was stopped and intravenous Vitamin K2 was given, so PT was normalized. Though estimate hemorrhage quantity reached 1,200 ml, we had no blood transfusion. The hematoma was completely diminished 4 months later, no reccurence has been occurred. Bucolome has especially pharmacokinetic positive interaction to Warfarin, so we must check PT-INR frequently.
Murosaki
Nobukazu
N
Department of Urology, Osaka Second Police Hospital.
Senoh
Hiroyuki
H
Takemoto
Masato
M
D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects*; D001281:Atrial Fibrillation / Q000150:complications; D001463:Barbiturates / Q000009:adverse effects; D006406:Hematoma / Q000139:chemically induced*; D006801:Humans; D019934:International Normalized Ratio; D008297:Male; D011517:Prothrombin Time; D013923:Thromboembolism / Q000517:prevention & control*; D014515:Ureteral Diseases / Q000139:chemically induced*; D014859:Warfarin / Q000009:adverse effects
D000925:Anticoagulants; D001463:Barbiturates; D014859:Warfarin; C084817:bucolome